Champions Oncology, Inc. (CSBR)
Largest Insider Buys in Sector
CSBR Stock Price History Chart
CSBR Stock Performance
About Champions Oncology, Inc.
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Insider Activity of Champions Oncology, Inc.
Over the last 12 months, insiders at Champions Oncology, Inc. have bought $441,769 and sold $0 worth of Champions Oncology, Inc. stock.
On average, over the past 5 years, insiders at Champions Oncology, Inc. have bought $166,483 and sold $2.65M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Mendelson Daniel Newman (director) — $441,769.
The last purchase of 1,000 shares for transaction amount of $6,500 was made by Mendelson Daniel Newman (director) on 2024‑01‑12.
List of Insider Buy and Sell Transactions, Champions Oncology, Inc.
| 2024-01-12 | Mendelson Daniel Newman | director | 1,000 0.0071% | $6.50 | $6,500 | -24.50% | ||
| 2024-01-11 | Mendelson Daniel Newman | director | 2,000 0.0147% | $6.27 | $12,540 | -19.27% | ||
| 2024-01-10 | Mendelson Daniel Newman | director | 2,944 0.022% | $6.31 | $18,577 | -18.55% | ||
| 2024-01-09 | Mendelson Daniel Newman | director | 3,000 0.0221% | $6.25 | $18,750 | -18.59% | ||
| 2024-01-08 | Mendelson Daniel Newman | director | 1,000 0.0074% | $6.15 | $6,150 | -17.78% | ||
| 2024-01-05 | Mendelson Daniel Newman | director | 2,000 0.0146% | $6.09 | $12,180 | -16.50% | ||
| 2024-01-04 | Mendelson Daniel Newman | director | 3,000 0.0221% | $6.12 | $18,360 | -15.90% | ||
| 2024-01-03 | Mendelson Daniel Newman | director | 500 0.0035% | $5.83 | $2,915 | -16.29% | ||
| 2023-12-21 | Mendelson Daniel Newman | director | 2,500 0.0184% | $4.92 | $12,300 | +5.29% | ||
| 2023-12-20 | Mendelson Daniel Newman | director | 2,100 0.015% | $4.82 | $10,122 | +4.12% | ||
| 2023-12-19 | Mendelson Daniel Newman | director | 5,000 0.0384% | $4.75 | $23,750 | +9.77% | ||
| 2023-10-11 | Mendelson Daniel Newman | director | 5,000 0.0385% | $6.40 | $32,000 | -13.78% | ||
| 2023-10-10 | Mendelson Daniel Newman | director | 1,100 0.008% | $6.41 | $7,051 | -16.59% | ||
| 2023-10-06 | Mendelson Daniel Newman | director | 1,530 0.0114% | $6.48 | $9,914 | -17.13% | ||
| 2023-10-05 | Mendelson Daniel Newman | director | 2,000 0.0156% | $6.47 | $12,940 | -13.71% | ||
| 2023-10-04 | Mendelson Daniel Newman | director | 5,000 0.0386% | $6.40 | $32,000 | -14.87% | ||
| 2023-10-03 | Mendelson Daniel Newman | director | 2,500 0.019% | $6.30 | $15,750 | -14.40% | ||
| 2023-09-29 | Mendelson Daniel Newman | director | 4,000 0.0294% | $6.16 | $24,640 | -13.04% | ||
| 2023-09-28 | Mendelson Daniel Newman | director | 5,000 0.0379% | $6.22 | $31,100 | -11.18% | ||
| 2023-09-27 | Mendelson Daniel Newman | director | 1,500 0.0115% | $5.95 | $8,925 | -6.57% |
Insider Historical Profitability
| Mendelson Daniel Newman | director | 198625 1.4611% | $4.96 | 30 | 2 | +54.24% |
| BROWN MICHAEL MAURICE | 10 percent owner | 22281040 163.9059% | $4.96 | 2 | 0 | |
| Battery Ventures IX, L.P. | 10 percent owner | 22281040 163.9059% | $4.96 | 2 | 0 | |
| Martell James | director | 2051828 15.0939% | $4.96 | 0 | 7 | |
| New Enterprise Associates 14, L.P. | 10 percent owner | 1713720 12.6066% | $4.96 | 0 | 1 | |
| ACKERMAN JOEL | director | 1021731 7.5162% | $4.96 | 10 | 1 | +66.02% |
| Morris Ronnie | CEO | 858878 6.3182% | $4.96 | 16 | 1 | +86.37% |
| BURKETT DOUGLAS D | President | 850 0.0063% | $4.96 | 3 | 0 | |
| Breitfeld Philip P. | director | 0 0% | $4.96 | 0 | 1 |
Institutional Investor Ownership
| Battery Management Corp | $11.87M | 17.82 | 2.42M | 0% | +$0 | 2.62 | |
| Nea Management Company Llc | $8.4M | 12.61 | 1.71M | 0% | +$0 | 0.1 | |
| Tocqueville Asset Management | $3.35M | 5.04 | 684,628 | +<0.01% | +$245.00 | 0.05 | |
| Renaissance Technologies | $611,000.00 | 0.92 | 124,691 | -0.08% | -$490.01 | <0.01 | |
| BlackRock | $566,847.00 | 0.85 | 115,683 | -0.36% | -$2,028.60 | <0.0001 | |
| The Vanguard Group | $419,460.00 | 0.63 | 85,604 | +3.34% | +$13,558.31 | <0.0001 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $378,280.00 | 0.57 | 77,200 | 0% | +$0 | 0.08 | |
| Goldman Sachs | $339,575.00 | 0.51 | 69,301 | New | +$339,575.00 | <0.0001 | |
| Geode Capital Management | $304,433.00 | 0.46 | 62,114 | +1.25% | +$3,749.42 | <0.0001 | |
| Northern Trust | $209,176.00 | 0.31 | 42,689 | -4.96% | -$10,917.19 | <0.0001 | |
| Morgan Stanley | $199,430.00 | 0.3 | 40,700 | +347.25% | +$154,840.00 | <0.0001 | |
| Hightower Advisors | $168,000.00 | 0.25 | 34,308 | +9.83% | +$15,033.23 | <0.0001 | |
| Acadian Asset Management | $148,000.00 | 0.23 | 30,697 | 0% | +$0 | <0.01 | |
| BNY Mellon | $131,070.00 | 0.2 | 26,749 | -13.08% | -$19,727.38 | <0.0001 | |
| State Street | $130,110.00 | 0.2 | 26,553 | 0% | +$0 | <0.0001 | |
| Bank of America | $126,547.00 | 0.19 | 25,826 | -0.01% | -$19.60 | <0.0001 | |
| Citadel Advisors LLC | $62,843.00 | 0.09 | 12,825 | -12.32% | -$8,829.87 | <0.0001 | |
| Mesirow Financial Investment Management Inc | $60,662.00 | 0.09 | 12,380 | New | +$60,662.00 | <0.01 | |
| Cambridge Investment Research Advisors Inc | $60,000.00 | 0.09 | 12,252 | New | +$60,000.00 | <0.0001 | |
| Stifel | $54,841.00 | 0.08 | 11,192 | New | +$54,841.00 | <0.0001 | |
| Simplex Trading Llc | $7,000.00 | 0.01 | 1,597 | New | +$7,000.00 | <0.0001 | |
| UBS | $5,424.00 | 0.01 | 1,107 | -50.34% | -$5,497.50 | <0.0001 | |
| JPMorgan Chase | $54.00 | <0.01 | 11 | -89% | -$436.91 | <0.0001 | |
| Wells Fargo | $230.00 | <0.01 | 47 | +2.17% | +$4.89 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 64 | -70.91% | -$0 | <0.0001 |